Literature DB >> 22089348

Reference genes for gene expression analysis by real-time reverse transcription polymerase chain reaction of renal cell carcinoma.

Henriette Bjerregaard1, Shona Pedersen, Søren Risom Kristensen, Niels Marcussen.   

Abstract

BACKGROUND: Differentiation between malignant renal cell carcinoma and benign oncocytoma is of great importance to choose the optimal treatment. Accurate preoperative diagnosis of renal tumor is therefore crucial; however, existing imaging techniques and histologic examinations are incapable of providing an optimal differentiation profile. Analysis of gene expression of molecular markers is a new possibility but relies on appropriate standardization to compare different samples. The aim of this study was to identify stably expressed reference genes suitable for the normalization of results extracted from gene expression analysis of renal tumors.
METHODS: Expression levels of 8 potential reference genes (ATP5J, HMBS, HPRT1, PPIA, TBP, 18S, GAPDH, and POLR2A) were examined by real-time reverse transcription polymerase chain reaction in tumor and normal tissue from removed kidneys from 13 patients with renal cell carcinoma and 5 patients with oncocytoma.
RESULTS: The expression levels of genes were compared by gene stability value M, average gene stability M, pairwise variation V, and coefficient of variation CV. More candidates were not suitable for the purpose, but a combination of HMBS, PPIA, ATP5J, and TBP was found to be the best combination with an average gene stability value M of 0.9 and a CV of 0.4 in the 18 tumors and normal tissues.
CONCLUSIONS: A combination of 4 genes, HMBS, PPIA, ATP5J, and TBP, is a possible reference in renal tumor gene expression analysis by reverse transcription polymerase chain reaction. A combination of four genes, HMBS, PPIA, ATP5J and TBP, being stably expressed in tissues from RCC is possible reference genes for gene expression analysis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22089348     DOI: 10.1097/PDM.0b013e318212e0a9

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  13 in total

1.  Effects of sialidase NEU1 siRNA on proliferation, apoptosis, and invasion in human ovarian cancer.

Authors:  Li-rong Ren; Li-ping Zhang; Shu-ying Huang; Yuan-fang Zhu; Wen-juan Li; Shan-yu Fang; Li Shen; Yan-ling Gao
Journal:  Mol Cell Biochem       Date:  2015-10-13       Impact factor: 3.396

2.  Over-expression of the ATP5J gene correlates with cell migration and 5-fluorouracil sensitivity in colorectal cancer.

Authors:  Hongbo Zhu; Linlin Chen; Wei Zhou; Zhongting Huang; Jingzi Hu; Sheng Dai; Xiaowei Wang; Xuefeng Huang; Chao He
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

3.  High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival.

Authors:  Maj Rabjerg; Aida Oliván-Viguera; Lars Koch Hansen; Line Jensen; Linda Sevelsted-Møller; Steen Walter; Boye L Jensen; Niels Marcussen; Ralf Köhler
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

4.  Recommendations for mRNA analysis of micro-dissected glomerular tufts from paraffin-embedded human kidney biopsy samples.

Authors:  Clemens L Bockmeyer; Juliane Wittig; Karen Säuberlich; Philipp Selhausen; Marc Eßer; Philip Zeuschner; Friedrich Modde; Kerstin Amann; Christoph Daniel
Journal:  BMC Mol Biol       Date:  2018-03-13       Impact factor: 2.946

5.  A frequent somatic mutation in the 3'UTR of GAPDH facilitates the development of ovarian cancer by creating a miR‑125b binding site.

Authors:  Peisen Liu; Yumin Zhong; Ting Cao; Xiujie Sheng; Huang Huang
Journal:  Oncol Rep       Date:  2020-06-25       Impact factor: 3.906

6.  In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself.

Authors:  Ines Breuksch; Jonas Welter; Heide-Katharina Bauer; Thorsten Enklaar; Sebastian Frees; Joachim W Thüroff; Annette Hasenburg; Dirk Prawitt; Walburgis Brenner
Journal:  Cell Commun Signal       Date:  2018-06-28       Impact factor: 5.712

7.  Identification of a suitable qPCR reference gene in metastatic clear cell renal cell carcinoma.

Authors:  Piotr M Wierzbicki; Jakub Klacz; Agnieszka Rybarczyk; Tomasz Slebioda; Marcin Stanislawowski; Agata Wronska; Anna Kowalczyk; Marcin Matuszewski; Zbigniew Kmiec
Journal:  Tumour Biol       Date:  2014-09-16

8.  GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression.

Authors:  Xiao-Rong Wu; Yong-Hui Chen; Wei Chen; Wen Kong; Ji-Wei Huang; Jin Zhang; Wei Xue; Dong-Ming Liu; Yi-Ran Huang
Journal:  Oncotarget       Date:  2016-06-21

9.  A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor Angiogenesis.

Authors:  Chris P Miller; Connor Tsuchida; Ying Zheng; Jonathan Himmelfarb; Shreeram Akilesh
Journal:  Neoplasia       Date:  2018-05-07       Impact factor: 5.715

10.  Identification of candidate genes and long non-coding RNAs associated with the effect of ATP5J in colorectal cancer.

Authors:  Bingjun Bai; Binbin Xie; Zongyou Pan; Lina Shan; Jianpei Zhao; Hongbo Zhu
Journal:  Int J Oncol       Date:  2018-02-22       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.